| scholarly article | Q13442814 |
| P2093 | author name string | Thomas N Wight | |
| Alan Chait | |||
| Shari Wang | |||
| Jay W Heinecke | |||
| John F Oram | |||
| Tsuyoshi Chiba | |||
| Tomas Vaisar | |||
| Mary Y Chang | |||
| Frederick C De Beer | |||
| Maria C De Beer | |||
| Timothy S McMillen | |||
| P2860 | cites work | The response-to-retention hypothesis of early atherogenesis | Q24629974 |
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Serum amyloid A, the major vertebrate acute-phase reactant | Q28145306 | ||
| Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixes | Q28291134 | ||
| Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications | Q28469007 | ||
| SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice | Q28511763 | ||
| Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction | Q28645861 | ||
| C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 | ||
| Impact of serum amyloid A on high density lipoprotein composition and levels | Q34187954 | ||
| Inflammation and atherosclerosis: role of C-reactive protein in risk assessment | Q35721270 | ||
| Enhanced extracellular lipid accumulation in acidic environments. | Q36589018 | ||
| Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans | Q37145550 | ||
| Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding | Q37383221 | ||
| Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes | Q40278061 | ||
| Serum amyloid A (SAA): an acute phase protein and apolipoprotein | Q40384379 | ||
| Eprodisate for the treatment of renal disease in AA amyloidosis. | Q40447968 | ||
| Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). | Q40530895 | ||
| Modified forms of low density lipoprotein and atherosclerosis | Q40889010 | ||
| Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice | Q40937418 | ||
| Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice | Q42592049 | ||
| High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease. | Q43109351 | ||
| The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project | Q43631877 | ||
| Apolipoprotein E mediates the retention of high-density lipoproteins by mouse carotid arteries and cultured arterial smooth muscle cell extracellular matrices | Q44044686 | ||
| Molecular basis of the association of arterial proteoglycans with low density lipoproteins: its effect on the structure of the lipoprotein particle | Q44198721 | ||
| Low-grade inflammation, endothelial activation and carotid intima-media thickness in type 2 diabetes | Q44981844 | ||
| Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice | Q44995472 | ||
| Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice | Q45212749 | ||
| Serum amyloid A and lipoprotein retention in murine models of atherosclerosis | Q45251426 | ||
| Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects | Q46531380 | ||
| Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits | Q46703887 | ||
| Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition | Q47206788 | ||
| Interaction of low density lipoproteins with arterial proteoglycans. The role of charge and sialic acid content. | Q54541224 | ||
| Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines | Q60746676 | ||
| Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Displacement of SAA from the HDL-SAA complex by apo AI and apo AII | Q70338833 | ||
| Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries | Q73083032 | ||
| Endotoxin suppresses mouse hepatic low-density lipoprotein-receptor expression via a pathway independent of the toll-like receptor 4 | Q73114538 | ||
| Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells | Q73212012 | ||
| Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis | Q73596679 | ||
| Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins | Q77133079 | ||
| The response-to-retention hypothesis of atherogenesis reinforced | Q77542561 | ||
| Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis | Q77743394 | ||
| Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans | Q78177623 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| lipopolysaccharide | Q421804 | ||
| P304 | page(s) | 1326-1332 | |
| P577 | publication date | 2011-04-07 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans | |
| P478 | volume | 31 |
| Q36236202 | A Cross-Sectional Study Demonstrating Increased Serum Amyloid A Related Inflammation in High-Density Lipoproteins from Subjects with Type 1 Diabetes Mellitus and How this Association Was Augmented by Poor Glycaemic Control. |
| Q28252254 | A brief elevation of serum amyloid A is sufficient to increase atherosclerosis |
| Q35153889 | Adipose tissue-derived human serum amyloid a does not affect atherosclerotic lesion area in hSAA1+/-/ApoE-/- mice |
| Q36709622 | ApoA-I mimetics: tomatoes to the rescue |
| Q35303738 | Apolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis: ex vivo and in vitro pro-inflammatory properties |
| Q92970082 | Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis |
| Q54260099 | Bifidobacterium breve B-3 exerts metabolic syndrome-suppressing effects in the liver of diet-induced obese mice: a DNA microarray analysis. |
| Q42151289 | Binding of plasma proteins to titanium dioxide nanotubes with different diameters. |
| Q35691485 | Distinct serum proteome profiles associated with collagen-induced arthritis and complete Freund's adjuvant-induced inflammation in CD38⁻/⁻ mice: The discriminative power of protein species or proteoforms |
| Q38773023 | Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy |
| Q87150366 | Effects of fractionated colostrum replacer and vitamins A, D, and E on haptoglobin and clinical health in neonatal Holstein calves challenged with Mycobacterium avium ssp. paratuberculosis |
| Q38293442 | Functionality of HDL: antioxidation and detoxifying effects |
| Q37695338 | HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes. |
| Q35904110 | HDL dysfunction in diabetes: causes and possible treatments |
| Q36167581 | Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartan |
| Q89783235 | High-Density Lipoprotein (HDL) Inhibits Serum Amyloid A (SAA)-Induced Vascular and Renal Dysfunctions in Apolipoprotein E-Deficient Mice |
| Q64245247 | High-Density Lipoprotein Function and Dysfunction in Health and Disease |
| Q34157008 | High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. |
| Q42848291 | High-density lipoprotein proteome dynamics in human endotoxemia. |
| Q33643266 | Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes |
| Q36037988 | Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease |
| Q60927660 | NFκB Inhibition Mitigates Serum Amyloid A-Induced Pro-Atherogenic Responses in Endothelial Cells and Leukocyte Adhesion and Adverse Changes to Endothelium Function in Isolated Aorta |
| Q28279562 | SAA does not induce cytokine production in physiological conditions |
| Q89433919 | Serum Amyloid A Is an Exchangeable Apolipoprotein |
| Q36430779 | Serum amyloid A impairs the antiinflammatory properties of HDL |
| Q36962846 | Serum amyloid A is found on ApoB-containing lipoproteins in obese humans with diabetes |
| Q35723642 | Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells |
| Q47756327 | Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axis |
| Q38293426 | Structure of HDL: particle subclasses and molecular components. |
| Q33742998 | Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3. |
| Q26827400 | Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology |
Search more.